×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [cder slide]
OGD Perspectives Gary J. Buehler, R.Ph. Director, Office of Generic Drugs October 26, 2005 GPhA Fall Technical Conference
216 views
History of the Montreal Protocol and 21 CFR 2.125 Robert J. Meyer, MD Director, ODE II / CDER
217 views
Tools to Reduce Phase III Trial Failures Lawrence J. Lesko, Ph.D., FCP Director of the Office of Clinical Pharmacology and Biopharmaceutics Center for
219 views
Copyright © 2005, SAS Institute Inc. All rights reserved. Maintaining a Validated SAS Toolset Co-Presenters: Edward Helton and Patricia Halley
217 views
History of the Montreal Protocol, FDA regulation of CFCs and Background to Meeting Robert J. Meyer, MD Director, ODE II / CDER
226 views
IND Review Chart (for submission of IND to CDER)
226 views